Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Tarih
2017
Yazar
Aygun, Aslan
Demirci, Emre
Toklu, Turkay
Karayel, Emre
Ocak, Meltem
Pehlivanoglu, Huseyin
Abuqbeitah, Mohammad
Kabasakal, Levent
Yeyin, Nami
Selcuk, Nalan Alan
Üst veri
Tüm öğe kaydını göster
Özet
Objective: The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617.
Bağlantı
http://hdl.handle.net/20.500.12627/131710
https://doi.org/10.4274/mirt.08760
Koleksiyonlar